Versartis $VSAR is targeting a $3 billion market with its Somavaratan. In order to value the company, I have assumed a 2019 launch for the drug in both adult and pediatric markets.

*** L3 or above subscription required to read the rest of the article ... Login or Subscribe/Upgrade here